gemcitabine has been researched along with Canine Diseases in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rodriguez, CO | 1 |
Abramo, F; Lorenzo, RM; Marconato, L; Ratto, A; Zini, E | 1 |
Bear, MD; Kulp, SK; London, CA; McMahon, MB; Pennell, ML | 1 |
Dubreuil, P; Hermine, O; Humbert, M; Kow, K; Mansfield, CD; Moussy, A; Rose, B; Thamm, DH | 1 |
Jeglum, AK; Lindner, D; Marconato, L; Nelson, V; Suslak-Brown, L; Zini, E | 1 |
Brodsky, EM; Elpiner, AK; Hazzah, TN; Post, GS | 1 |
Chew, DJ; de Brito Galvao, JF; Inpanbutr, N; Kisseberth, WC; Murahari, S; Sutayatram, S | 1 |
Kitchell, BE; Moore, AS | 1 |
2 review(s) available for gemcitabine and Canine Diseases
Article | Year |
---|---|
Using canine osteosarcoma as a model to assess efficacy of novel therapies: can old dogs teach us new tricks?
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Aerosols; Animals; Antineoplastic Agents; Bone Neoplasms; Child; Deoxycytidine; Dog Diseases; Dogs; Gemcitabine; Humans; Interleukin-2; Lung Neoplasms; Molybdenum; Osteosarcoma; Phosphatidylethanolamines; Signal Transduction | 2014 |
New chemotherapy agents in veterinary medicine.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Deoxycytidine; Dog Diseases; Dogs; Gemcitabine; Ifosfamide; Lomustine; Mesna; Neoplasms; Streptozocin; Veterinary Drugs | 2003 |
1 trial(s) available for gemcitabine and Canine Diseases
Article | Year |
---|---|
Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Gemcitabine; Male; Piroxicam; Urinary Bladder Neoplasms | 2011 |
5 other study(ies) available for gemcitabine and Canine Diseases
Article | Year |
---|---|
Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs.
Topics: Animals; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Dog Diseases; Dogs; Female; Gemcitabine; Infusions, Intravenous; Mammary Neoplasms, Animal; Neoplasm Metastasis; Prospective Studies; Quality of Life; Treatment Outcome | 2008 |
Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
Topics: Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Carboplatin; Cell Line, Tumor; Cell Survival; Deoxycytidine; Diphosphonates; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gemcitabine; Osteosarcoma; Pamidronate | 2010 |
Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept study.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Deoxycytidine; Dog Diseases; Dogs; Doxorubicin; Drug Synergism; Gemcitabine; Inhibitory Concentration 50; Piperidines; Protein Kinase Inhibitors; Pyridines; Sarcoma; Thiazoles; Vinblastine | 2012 |
Single-agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Deoxycytidine; Dog Diseases; Dogs; Female; Gemcitabine; Liver Neoplasms; Male; Survival Analysis; Treatment Outcome; Ultrasonography | 2011 |
Effects of gemcitabine and gemcitabine in combination with carboplatin on five canine transitional cell carcinoma cell lines.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Carboplatin; Carcinoma, Transitional Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dog Diseases; Dogs; Drug Synergism; Drug Therapy, Combination; Gemcitabine | 2012 |